Medicaid: BIO Comments to Arizona on Specialty Pharmacy Drugs and Services Programs

Comments expressing concerns that the contract described in the RFP appears to be incompatible with the 340B program’s requirement that discounted drugs be dispensed only to patients of the entity receiving the discount, a requirement intended to prevent diversion of discounted drugs to unintended and often fully insured patients.

Read the letter